Tech Company Financing Transactions
Arete Therapeutics Funding Round
On 2/21/2005, Arete Therapeutics raised $15 million in Series A investment from Frazier Healthcare Partners, Alta Partners and Burrill & Company.
Transaction Overview
Company Name
Announced On
2/21/2005
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Frazier Healthcare Partners (Lead Investor) (James Topper)
Alta Partners (Daniel Janney)
Three Arch Partners (Richard Lin)
Proceeds Purpose
The privately held company said it will use the money to pursue pre-clinical and clinical development of its compounds for cardiovascular, inflammatory and urologic disorders.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
7000 Shoreline Ct. 201
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Arete Therapeutics Inc. is discovering and developing first in class small molecule drugs directed at novel targets for cardiovascular diseases and inflammation. The Company's proprietary therapies are directed at a new branch of arachidonic acid metabolism, which is a proven (US $10+B) pathway for therapeutic intervention in a variety of inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Sabry
Chief Medical Officer
Randall Whitcomb
Vice President
Euan MacIntyre
Browse more venture capital transactions:
Prev: 2/18/2005: SugarCRM venture capital transaction
Next: 2/22/2005: RealOps venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs